Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Lineage Cell Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
STAAR Surgical Company June 18, 202698.8%
-
Lineage Cell Therapeutics Inc. June 9, 202698.8%
-
Lineage Cell Therapeutics Inc. June 26, 202598.4%
-
Lineage Cell Therapeutics Inc. June 11, 202497.7%
-
Lineage Cell Therapeutics Inc. September 6, 202397.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2026 | Insight Molecular Diagnostics Inc. | Open-market purchase | +521,739 | $5.75 | $2,999,999 |
| Feb 10, 2026 | Insight Molecular Diagnostics Inc. | Open-market purchase | +0 | — | — |
| Jan 9, 2026 | STAAR Surgical Company | Open-market purchase | +27,485 | $22.05 | $606,044 |
| Jan 9, 2026 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Jan 8, 2026 | STAAR Surgical Company | Open-market purchase | +3,240 | $21.94 | $71,086 |
| Jan 8, 2026 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Jan 7, 2026 | STAAR Surgical Company | Open-market purchase | +66,467 | $22.00 | $1,462,274 |
| Jan 7, 2026 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Jan 6, 2026 | STAAR Surgical Company | Open-market purchase | +186,946 | $21.01 | $3,927,735 |
| Jan 6, 2026 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Jan 6, 2026 | STAAR Surgical Company | Open-market purchase | +150,000 | $22.38 | $3,357,000 |
| Jan 6, 2026 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Nov 21, 2025 | STAAR Surgical Company | Open-market purchase | +797,486 | $27.86 | $22,217,960 |
| Nov 21, 2025 | STAAR Surgical Company | Open-market purchase | +0 | — | — |
| Nov 20, 2025 | STAAR Surgical Company | Open-market purchase | +393,382 | $27.14 | $10,676,387 |
Questions about Neal C. Bradsher
What boards is Neal C. Bradsher on?
Neal C. Bradsher sits on the boards of Lineage Cell Therapeutics Inc. and STAAR Surgical Company.
How long has Neal C. Bradsher served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.